Halozyme Therapeutics, Inc.
HALO
$107.39
-$0.92-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -57.86% | -57.40% | -76.04% | 5.35% | 3.62% |
| Total Receivables | 44.09% | 50.35% | 43.06% | 21.10% | 47.46% |
| Inventory | -24.45% | -5.70% | 24.40% | 41.38% | 13.93% |
| Prepaid Expenses | 41.23% | 58.14% | 65.95% | 118.21% | -9.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.89% | -20.52% | -23.97% | 17.90% | 13.65% |
|
|
|||||
| Total Current Assets | -16.89% | -20.52% | -23.97% | 17.90% | 13.65% |
| Net Property, Plant & Equipment | 17.83% | 12.93% | 9.46% | -4.12% | -4.64% |
| Long-term Investments | 39.56% | 39.71% | 39.23% | 0.00% | 0.00% |
| Goodwill | 39.56% | 39.71% | 39.23% | 0.00% | 0.00% |
| Total Other Intangibles | 151.82% | 147.86% | 144.25% | -16.93% | -16.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.95% | -12.54% | -33.51% | -30.51% | 45.92% |
| Total Assets | 25.49% | 21.68% | 22.38% | 4.87% | 4.29% |
|
|
|||||
| Total Accounts Payable | 26.31% | -29.77% | 103.91% | 23.89% | 21.13% |
| Total Accrued Expenses | -3.23% | 7.72% | 12.47% | 15.31% | 152.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 156.50% | 141.53% | 27.31% | 669.40% | 0.69% |
|
|
|||||
| Total Current Liabilities | 156.50% | 141.53% | 27.31% | 669.40% | 0.69% |
| Long-Term Debt | 28.40% | 28.42% | 42.29% | -46.81% | 0.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.04% | 10.30% | -- | -8.63% | -5.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 145.63% | 349.44% | 143.79% | 140.32% | 257.58% |
| Total Liabilities | 41.41% | 43.10% | 45.71% | 3.12% | 2.45% |
|
|
|||||
| Common Stock & APIC | -3.39% | 256.32% | 9,753.66% | -61.25% | -99.62% |
| Retained Earnings | -58.10% | -57.14% | -84.78% | 26.29% | 38.53% |
| Treasury Stock & Other | 72.43% | -272.19% | -572.50% | -220.77% | -1,273.45% |
| Total Common Equity | -56.86% | -54.46% | -86.58% | 11.31% | 14.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -56.86% | -54.46% | -86.58% | 11.31% | 14.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -56.86% | -54.46% | -86.58% | 11.31% | 14.97% |
|
|
|||||